Trial Site Detail

 

Drug:
Imatinib
Trial:
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Hôpital Jean Minjoz

     
Besancon , Doubs 25030
France

 

Principal Investigator:
 Elsa Kalbacher
Contact:
 Elsa KALBACHER, Doctor + 33 3 81 66 81 66 ekalbacher@chu-besancon.fr
Activation Status of this Site:
 Active
Notes about this Site:
Hôpital Jean Minjoz Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.